- How deals are shaping the $450 billion industry that manages prescriptions in the United States.
- Leaders must act quickly to overcome obstacles so they can harness revenue opportunities for the industry and health benefits for society.
- As large companies join forces to tackle healthcare, they will accelerate innovation and disruption in the broader industry.
- As the massive healthcare program for low-income U.S. residents evolves, players will have to develop new capabilities.
- To thrive in the growing MA market, a culture of regulatory compliance is key.
- In a turbulent environment, it is vital for healthcare companies to build business models that can withstand uncertainty and change.
- December 7, 2017 by Ram CharanIt’s a case study in the “attacker’s advantage.”
- As the healthcare landscape evolves, stakeholders in the pharmacy value chain need to rethink how they organize to deliver value.
- To capitalize on the rapid growth in membership, insurers need to rethink the way they design and administer MA plans.
- Payors, providers, medtech companies, and pharmaceutical firms need to get better at working with one another.
- June 12, 2017 by Theodore KinniIn his new book, Mistreated, former Permanente Medical Group CEO Robert Pearl diagnoses the woes afflicting one of the country’s largest industries.
- How healthcare providers can create resilience and opportunities in a period of uncertainty.
- Pursuing effective growth strategies will help firms navigate the uncertainty in the U.S. market.
- People don’t crave the latest fitness wearable. Their overwhelming preference is for simple applications that provide and organize information.
- A comprehensive model shows how far-reaching trends in the massive industry will influence the growth of profit pools — and how payors and providers should respond.
- The health insurer is leading the way for the reformation of the U.S. healthcare system by saving consumers money and testing innovative ideas.
All articles tagged: healthcare payers
Videos, Galleries, & More
The ninth annual report offers a quantitative market outlook to 2035.